# Effect of Oral Adenosine-triphosphate (ATP) on Human Muscle Performance

> **NCT01141504** · PHASE1 · COMPLETED · sponsor: **Metabolic Technologies Inc.** · enrollment: 16 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DIETARY_SUPPLEMENT:** PeakATP 250
- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** PeakATP 400
- **DIETARY_SUPPLEMENT:** PeakATP 400 plus proprietary blend

## Key facts

- **NCT ID:** NCT01141504
- **Lead sponsor:** Metabolic Technologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01141504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01141504, "Effect of Oral Adenosine-triphosphate (ATP) on Human Muscle Performance". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01141504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*